TY - JOUR
AU - Hamidi Alamdari, Daryoush
AU - Hafizi Lotfabadi, Saied
AU - Agheli-Rad, Marzieh
AU - Barazandeh Ahmadabadi, Fatemeh
AU - Morovatdar, Negar
AU - Bagheri-Moghaddam, Ahmad
AU - Safari, Hossin
AU - Mozdourian, Mahnaz
AU - Peivandi, Yazdi, Arash
AU - Ali-Zeraati, Abass
AU - Sedaghat, Alireza
AU - Poursadegh, Farid
AU - Tavousi, Seyed M.
AU - Vojouhi, Shohreh
AU - Amini, Shahram
AU - Amini, Mahnaz
AU - Majid-Hosseini, Seyed
AU - Tavanaee-Sani, Ashraf
AU - Ghiabi, Amin
AU - Nabavi-Mahalli, Shima
AU - Rajabi, Omid
AU - Koliakos, George
PY - 2021
DA - July
TI - Methylene Blue for Treatment of Hospitalized COVID-19 Patients, Randomized, Controlled, Open-Label Clinical Trial, Phase 3
JO - Revista de Investigación Clínica
EP - 198
VL - 73
IS - 3
DO - https://doi.org/10.24875/ric.21000028
AB - Background:There is no pharmacological intervention on the treatment of hypoxemia and respiratory distress in COVID-19 patients.
PB - Permanyer
UR - https://aura.abdn.ac.uk/handle/2164/16825
KW - Coronavirus (COVID-19)
KW - Hospital care
ER